Bing

SEARCH HISTORY

BERKELEY, CA--(Marketwired - Jul 22, 2015) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced the pricing of a previously announced underwritten public offering of 4,545,455 shares of its common stock, offered at a price to the public …
Reuters · 7/22/2015
BERKELEY, CA--(Marketwired - Jul 28, 2015) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced the completion of an underwritten public offering of 5,227,273 shares of its common stock, including 681,818 shares sold pursuant to the …
Digital Journal · 7/28/2015
Dynavax Technologies (NASDAQ:DVAX) has been given an average broker rating score of 1.00 (Strong Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. Three investment analysts have rated the stock
wkrb13.com · 5/21/2015
RA Capital has averaged a 38% annualized return over the past 13 years. The fund owns almost 7% of DVAX. Learn more about stocks owned by influential billionaire investors, and potential takeover targets, by following us at BillionairesPortfolio.com.
Forbes · 6/24/2014
New York, NY – (NISMAGAZINE) –09/30/2013- Atmel Corporation (NASDAQ:ATML) fell 1.34% to $7.36 after trading 2.98M shares. The company is a worldwide leader in the design and manufacture of microcontrollers, capacitive touch solutions, advanced …
Nautilus Investment Strategies Magazine · 9/30/2013
Now that 2014 is coming to an end, what stocks should investors be on the lookout for in the ... Dynavax Technologies Corporation (NASDAQ: DVAX) is known for developing products to prevent and treat infectious and inflammatory diseases and cancer.
Benzinga · 12/26/2014
RA Capital initiated a stake in Dynavax Technologies Corporation (NASDAQ:DVAX) during the first ... a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300) This is a FREE report from Insider Monkey. Credit Card is NOT …
INSIDER MONKEY · 6/29/2015
Nonetheless, our universe still features multiple smid cap stocks that trade at a modest 1-2x multiple of their peak sales potential (CEMP, CLDX, DVAX, ITCI, OPHT, RLYP, SNSS). Moreover, the large cap, earnings-driven companies continue to trade on P/E ...
Barron's · ByJohanna Bennett · 7/17/2015
Now the stock has dropped for a third time. Another FDA decision was behind the latest drop, which saw Dynavax ($DVAX) shares close down 43% on Monday. The U.S. regulator asked for more data to support Heplisav, the hepatitis B vaccine Dynavax is …
Fierce Vaccines · 6/12/2013
... site for information on small cap stocks and penny stocks since 1999, to receive the free SmallCapReview newsletter visit http://www.smallcapreview.com. Dynavax Technologies Corporation (Nasdaq: DVAX) $1.49. Today announced data from two studies …
TransWorldNews · 1/26/2010